Related Experiment Videos
Structure-activity relationship for antiarrhytmic actions of -receptor blocking drugs
European Journal of Pharmacology
|May 1, 1971
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Neonatal sepsis in a tertiary care center in central India: microbiological profile, antimicrobial sensitivity pattern and outcome.
Journal of neonatal-perinatal medicine·2013
Combined terazosin and verapamil therapy in essential hypertension. Hemodynamic and pharmacokinetic interactions.
American journal of hypertension·1995
Analysis of adverse events in a dose titration study.
Journal of clinical pharmacology·1994
Effect of atrial natriuretic peptide (8-33-Met ANP) in patients with hypertension.
American journal of hypertension·1992
Terazosin: pharmacokinetics and the effect of age and dose on the incidence of adverse events.
American heart journal·1991
Antihypertensive dose-response relationships: studies with the selective alpha 1-blocking agent terazosin.
American heart journal·1991
FGF-21 Protects Against Sepsis-Associated Acute Kidney Injury by Modulating Inflammation and Autophagy via the AMPK/mTOR1 Pathway.
European journal of pharmacology·2026
Obesity associated inflammatory perivascular adipose tissue promotes endothelial inflammation and atherosclerosis in mice.
European journal of pharmacology·2026
Imidazo[1,2-a]pyridine-based HDAC6 inhibitor a17 for the treatment of Alzheimer's disease.
European journal of pharmacology·2026
Highly Potent and Selective TRPM2 Inhibitors: Therapeutic Effects and Mechanisms in Acute Lung Injury.
European journal of pharmacology·2026
Targeting of NLRP3 Gln624/Ser658 by Carabrone attenuates inflammatory diseases.
European journal of pharmacology·2026
Fraxin alleviates myocardial infarction dysfunction by decreasing oxidative stress via PI3K/AKT-mediated upregulation of HXK2.
European journal of pharmacology·2026
Implementation of the In Vitro Seizure Liability Assay (iLAseizure) in Drug Discovery and Development: Mechanism of Action Case Studies.
Pharmacology research & perspectives·2026
In Silico Evaluation of Annonaceous Acetogenins as Potential HER2 and MELK Inhibitors for Targeted Cancer Therapy.
Anti-cancer agents in medicinal chemistry·2026
Chalcones as a Platform for the Development of Novel Antiviral Agents: A Review.
Mini reviews in medicinal chemistry·2026